Atlas Trials

Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.

Clinical trial NCT04425655 · TERMINATED

Trial details

NCT number
NCT04425655
Sponsor
University of California, San Diego
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia, AdultAMLAML, Adult
Start date
2020-08-05
Primary completion
2022-07-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.